Diversified Energy Delivers Strong FY25 Results With EBITDA Beat And New Acquisition, Tennyson Securities 4 March 2026
Union Jack Oil Accelerates Growth with UK Production Boost and US Exploration Upside, Zeus Capital 10 July 2025
European fund opportunities: monetary and fiscal stimulus supports JEDT’s outperformance 2 March 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a 110% Upside Potential in the Asset Management Sector 5 March 2026
Spire Healthcare Group PLC (SPI.L) Investor Outlook: Unlocking a 38.77% Potential Upside 5 March 2026
Sequoia Economic Infrastructure (SEQI.L) Stock Analysis: High Dividend Yield and Promising Upside 5 March 2026
Supermarket Income REIT PLC ORD (SUPR.L) Stock Analysis: A High Dividend Yield Amidst Modest Upside 5 March 2026
Senior PLC (SNR.L) Stock Analysis: Navigating Growth with a 1.02% Dividend Yield in the Aerospace & Defense Sector 5 March 2026
Diversified Energy Delivers Strong FY25 Results With EBITDA Beat And New Acquisition, Tennyson Securities 4 March 2026
Union Jack Oil Accelerates Growth with UK Production Boost and US Exploration Upside, Zeus Capital 10 July 2025
European fund opportunities: monetary and fiscal stimulus supports JEDT’s outperformance 2 March 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a 110% Upside Potential in the Asset Management Sector 5 March 2026
Spire Healthcare Group PLC (SPI.L) Investor Outlook: Unlocking a 38.77% Potential Upside 5 March 2026
Sequoia Economic Infrastructure (SEQI.L) Stock Analysis: High Dividend Yield and Promising Upside 5 March 2026
Supermarket Income REIT PLC ORD (SUPR.L) Stock Analysis: A High Dividend Yield Amidst Modest Upside 5 March 2026
Senior PLC (SNR.L) Stock Analysis: Navigating Growth with a 1.02% Dividend Yield in the Aerospace & Defense Sector 5 March 2026
AstraZeneca Plc Farxiga significantly reduced hospitalisation for heart failure or CV death 12 November 2018
AstraZeneca PLC Returns to Sales Growth; New Medicines and Emerging Markets Lead the Way 8 November 2018
AstraZeneca Plc agreement to divest the prescription medicine rights to Nexium in Europe 30 October 2018
AstraZeneca Plc Agreement with Cheplapharm for rights to Atacand in 28 European countries completed 1 October 2018
AstraZeneca PLC sell commercial rights to Atacand and Atacand Plus to Cheplapharm in Europe 24 July 2018
Accesso Technology Group plc: What’s Driving Revenue and Resilience Amid Global Headwinds (Video) 10 June 2025
ICG Enterprise Trust: Mid-Teens Growth and 5.4x Returns, Why the Market Is Missing This (Video) 6 June 2025
Tritax Big Box REIT highlights rental growth, data centre progress and capital recycling in FY25 update 22 January 2026
Union Jack Oil Accelerates Growth with UK Production Boost and US Exploration Upside, Zeus Capital 10 July 2025
European fund opportunities: monetary and fiscal stimulus supports JEDT’s outperformance 2 March 2026
Diversified Energy Delivers Strong FY25 Results With EBITDA Beat And New Acquisition, Tennyson Securities 4 March 2026
Syncona Limited (SYNC.L) Stock Analysis: Exploring a 110% Upside Potential in the Asset Management Sector 5 March 2026
Spire Healthcare Group PLC (SPI.L) Investor Outlook: Unlocking a 38.77% Potential Upside 5 March 2026
Sequoia Economic Infrastructure (SEQI.L) Stock Analysis: High Dividend Yield and Promising Upside 5 March 2026
Supermarket Income REIT PLC ORD (SUPR.L) Stock Analysis: A High Dividend Yield Amidst Modest Upside 5 March 2026
Senior PLC (SNR.L) Stock Analysis: Navigating Growth with a 1.02% Dividend Yield in the Aerospace & Defense Sector 5 March 2026
